Literature DB >> 27728950

Robotic Hernia Repair.

Nathaniel Stoikes1, David Webb1, Guy Voeller1.   

Abstract

The use of the da Vinci robot for inguinal and ventral hernia repair has exponentially increased over the last five years. This increase is occurring in spite of historical cost analyses showing robotic surgery to be cost prohibitive for other general surgery procedures. Specific data regarding outcomes and cost analysis for hernia is lacking. The increase in robotic hernia repairs is likely related to intangible factors such as enhanced visualization, articulating instruments, and hospital resources. Further study of robotic hernia repair is needed prospectively as its use increases to delineate the true benefits.

Entities:  

Mesh:

Year:  2016        PMID: 27728950

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  4 in total

1.  Inguinal hernia repair: is there a benefit to using the robot?

Authors:  Eric J Charles; J Hunter Mehaffey; Carlos A Tache-Leon; Peter T Hallowell; Robert G Sawyer; Zequan Yang
Journal:  Surg Endosc       Date:  2017-10-24       Impact factor: 4.584

2.  Robotic-assisted compared with laparoscopic incisional hernia repair following oncologic surgery: short- and long-term outcomes of a randomized controlled trial.

Authors:  Thiago Nogueira Costa; Ricardo Zugaib Abdalla; Francisco Tustumi; Ulysses Ribeiro Junior; Ivan Cecconello
Journal:  J Robot Surg       Date:  2022-03-30

3.  Robotic-assisted laparoscopic groin hernia repair: observational case-control study on the operative time during the learning curve.

Authors:  Filip Muysoms; Stijn Van Cleven; Iris Kyle-Leinhase; Conrad Ballecer; Archana Ramaswamy
Journal:  Surg Endosc       Date:  2018-05-15       Impact factor: 4.584

4.  Robotic-assisted and laparoscopic hernia repair: real-world evidence from the Americas Hernia Society Quality Collaborative (AHSQC).

Authors:  Melissa LaPinska; Kyle Kleppe; Lars Webb; Thomas G Stewart; Molly Olson
Journal:  Surg Endosc       Date:  2020-03-31       Impact factor: 4.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.